ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹372 Cr | ₹241 Cr | ₹142 Cr | ₹175 Cr | ₹2,346 Cr |
What is the latest Total Current Liabilities ratio of ORCHID PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹372 Cr |
Mar2022 | ₹241 Cr |
Mar2021 | ₹142 Cr |
Mar2020 | ₹175 Cr |
Mar2019 | ₹2,346 Cr |
How is Total Current Liabilities of ORCHID PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹372 Cr | 54.45 | |
Mar2022 | ₹241 Cr | 69.46 | |
Mar2021 | ₹142 Cr | -18.78 | |
Mar2020 | ₹175 Cr | -92.54 | |
Mar2019 | ₹2,346 Cr | - |
Compare Total Current Liabilities of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹5,529.1 Cr | 7.4% | -0.4% | 149% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,470.0 Cr | 0.4% | -0.4% | 61.2% | Stock Analytics | |
CIPLA | ₹112,990.0 Cr | -1.1% | 1.7% | 53.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,846.0 Cr | 5.9% | 11.3% | 94.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,849.0 Cr | -0.1% | 3.9% | 20% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,742.1 Cr | -2% | -4.2% | 29.3% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | 7.4% |
-0.4% |
149% |
SENSEX | 1.7% |
0.7% |
19.2% |
You may also like the below Video Courses